Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Neurology Drugs Market Research Reports

Titlepublishedprice

China Neuromyelitis Optica Drug Market Research Report 2017

By QYResearch Group
"...... enue and market share for each manufacturer, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs? - Nang Kuang - Tianjin Kingyork - Baxter? - CSL? - Grifols?......"
13-Jan-2017$3200

Global Neuromyelitis Optica Drug Sales Market Report 2017

By QYResearch Group
"...... uses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs? - Nang ......"
13-Jan-2017$4000

Europe Neuromyelitis Optica Drug Market Report 2017

By QYResearch Group
"...... nd Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs?......"
12-Jan-2017$3900

Global Myasthenia Gravis Drugs Market 2017-2021

By Technavio
"...... ecast period. For instance, Alexion Pharmaceuticals is currently developing a monoclonal antibody, Soliris, for the treatment of myasthenia gravis. Once launched around end 2017 or beginning of 2018, this drug is expected to be the blockbuster drug f......"
12-Jan-2017$3500

United States Neuromyelitis Optica Drug Market Report 2017

By QYResearch Group
"...... enue and market share for each player, covering - Pfizer? - Fresenius? - TEVA? - Sandoz? - Intas - Gyjtrs? - Nang Kuang - Tianjin Kingyork - Baxter? - CSL? - Grifols? ......"
11-Jan-2017$3800

Relpax -Drug Insights, 2017

By Delve Insight
"...... the Relpax sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Relpax, patents information and exclusivity data, route of synthesis, competitive landscape,......"
01-Jan-2017$1000

Strattera -Drug Insights, 2017

By Delve Insight
"...... provides the Strattera sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Strattera, patents information and exclusivity data, route of synthesis, competi......"
01-Jan-2017$1000

Alcohol Addiction-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Treximet -Drug Insights, 2017

By Delve Insight
"...... ovides the Treximet sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Treximet, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2017

By Delve Insight
"...... ent including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundin......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.